These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 25323956)

  • 1. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
    Liu S; Zhang W; Liu K; Ji B; Wang G
    Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
    Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
    Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.
    Yang CL; Jiang FQ; Xu F; Jiang GX
    Tumour Biol; 2012 Oct; 33(5):1535-41. PubMed ID: 22581584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
    Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
    Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells.
    Yue Y; Shao Y; Luo Q; Shi L; Wang Z
    Biomed Res Int; 2013; 2013():434561. PubMed ID: 23936798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disintegrin and metalloprotease (ADAM)10 is highly expressed in hepatocellular carcinoma and is associated with tumour progression.
    Zhang W; Liu S; Liu K; Wang Y; Ji B; Zhang X; Liu Y
    J Int Med Res; 2014 Jun; 42(3):611-8. PubMed ID: 24670536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of ADAM10 inhibits migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis.
    Li D; Xiao Z; Wang G; Song X
    Mol Med Rep; 2015 Oct; 12(4):5517-23. PubMed ID: 26135838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
    Doberstein K; Pfeilschifter J; Gutwein P
    Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
    Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
    World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-365 targets ADAM10 and suppresses the cell growth and metastasis of hepatocellular carcinoma.
    Liu Y; Zhang W; Liu S; Liu K; Ji B; Wang Y
    Oncol Rep; 2017 Mar; 37(3):1857-1864. PubMed ID: 28184920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baculovirus-mediated miRNA regulation to suppress hepatocellular carcinoma tumorigenicity and metastasis.
    Chen CL; Wu JC; Chen GY; Yuan PH; Tseng YW; Li KC; Hwang SM; Hu YC
    Mol Ther; 2015 Jan; 23(1):79-88. PubMed ID: 25023326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding LINC01551 promotes hepatocellular carcinoma cell proliferation, migration, and invasion by acting as a competing endogenous RNA of microRNA-122-5p to regulate ADAM10 expression.
    Gao J; Yin X; Yu X; Dai C; Zhou F
    J Cell Biochem; 2019 Oct; 120(10):16393-16407. PubMed ID: 31270840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10.
    Xu Y; Lai Y; Cao L; Li Y; Chen G; Chen L; Weng H; Chen T; Wang L; Ye Y
    RNA Biol; 2021 Oct; 18(10):1408-1423. PubMed ID: 33206588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
    Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
    Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway.
    Wu L; Zheng J; Chen P; Liu Q; Yuan Y
    Biomed Pharmacother; 2017 Jun; 90():705-712. PubMed ID: 28419966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.